Evaluation of antiseizure activity of essential oil from roots of Angelica archangelica Linn. in mice

Indian Journal of Pharmaceutical Sciences

Volumn 72, Issue 3, 2010, Pages 371-375

  Pathak, Shalini ^a   Wanjari, M M ^b   Jain, S K ^a   Tripathi, M ^c  

^a BUNDELKHAND UNIVERSITY   (India)

^b Central Research Institute (Ayurveda)   (India)

^c School of Pharmaceutical Science   (India)

Author keywords

Angelica archangelica (Umbelliferae); convulsions; maximal electroshock; medicinal plants; pentylenetetrazol

Indexed keywords

ARACHIS OIL; DIAZEPAM; ESSENTIAL OIL; PENTETRAZOLE; PHENYTOIN;

ANGELICA ARCHANGELICA; ANIMAL EXPERIMENT; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ELECTRIC SHOCK; FEMALE; LD 50; MALE; MOTOR DYSFUNCTION; MOUSE; NONHUMAN; PHYSICAL CHEMISTRY; PLANT ROOT; SEIZURE;

EID: 77957748533     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: 10.4103/0250-474X.70487     Document Type: Article

References (25)

1. The Wealth of India, A dictionary of Indian raw materials and industrial products raw materials. Vol 1. A revised ed. New Delhi: Council of Scientific and Industrial Research; 2003. p. 275-6.
2. Salikhova RA, Poroshenko GG. Antimutagenic properties of Angelica archangelica L. Vestn Ross Akad Med Nauk 1995;1:58-61.
3. Khayyal MT, El-Ghazaly MA, Kenawy SA, Seif-el-Nasr M, Mahran LG, Kafafi YA, et al. Antiulcerogenic effect of some gastrointestinally acting plant extracts and their combination. Arzneimittelforschung 2001;51:545-53.
4. Yeh ML, Liu CF, Huang CL, Huang TC. Hepatoprotective effect of Angelica archangelica in chronically ethanol-treated mice. Pharmacology 2003;68:70-3.
5. Sigurdsson S, Ogmundsdottir HM, Gudbjarnason S. Antiproliferative effect of Angelica archangelica fruits. Z Naturforsch [C] 2004;59:523-7.
6. Sigurdsson S, Ogmundsdottir HM, Hallgrimsson J, Gudbjarnason S. Antitumour activity of Angelica archangelica leaf extract. In Vivo 2005;19:191-4.
7. Sigurdsson S, Ogmundsdottir HM, Gudhjarnason S. The cytotoxic effect of two chemotypes of essential oils from the fruits of Angelica archangelica L. Anticancer Res 2005;25 B: 1877-80.
8. Chen SW, Min L, Li WJ, Kong WX, Li JF, Zhang YJ. The effects of angelica essential oil in three murine tests of anxiety. Pharmacol Biochem Behav 2004;79:377-82.
9. Min L, Chen SW, Li WJ, Wang R, Li YL, Wang WJ, et al. The effects of angelica essential oil in social interaction and hole-board tests. Pharmacol Biochem Behav 2005;81:838-42.
10. Sharma PV. Medhyadi Varg. In: Sharma PV, editor. Dravya Gun-Vijnana, Vegetable drugs. Vol 2. Varanasi: Chaukhambha Bharti Academy; 2005. p. 34-5.
11. Nivinskiene O, Butkiene R, Mockute D. Changes in the chemical composition of essential oil of Angelica archangelica L. roots during storage. Chemija (Vilnius) 2003;14:52-6.
12. Librowski T, Czarnecki R, Mendyk A, Jastrzebska M. Influence of new monoterpene homologues of GABA on the central nervous system activity in mice. Pol J Pharmacol 2000;52:317-21.
13. Brum LF, Elisabetsky E, Souza D. Effects of linalool on [(3) H] MK801 and [(3) H] muscimol binding in mouse cortical membranes. Phytother Res 2001;15:422-5. (Pubitemid 32762391)
14. Chalchat JC, Garry RP. Essential oil of Angelica roots (Angelica archangelica L.): optimization of distillation, location in plant and chemical composition. J Essen Oil Res 1997;9:311-9.
15. Consroe P, Martin A, Singh V. Antiepileptic potential of cannabidiol analogs. J Clin Pharmacol 1981;21:428S-36S.
16. Sayyah M, Nadjafnia L, Kamalinejad M. Anticonvulsant activity and chemical composition of Artemisia dracunculus L. essential oil. J Ethnopharmacol 2004;94:283-7.
17. Kulkarni SK. Handbook of experimental pharmacology. 3rd ed. New Delhi: Vallabh Prakashan; 1999. p. 131-4.
18. Cartmell SM, Gelgor L, Mitchell D. A revised-rota rod procedure for measuring the effect of antinociceptive drugs on motor function in the rat. J Pharmacol Methods 1991;26:149-59.
19. Hosseinzadeh H, Nassiri Asl M. Anticonvulsant, sedative and muscle relaxant effects of carbenoxolone in mice. BMC Pharmacol 2003;3:3.
20. Loscher W, Schmidt D. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res 1988;3:145-81.
21. Luszczki JJ, Glowniak K, Czuczwar SJ. Time-course and dose-response relationships of imperatorin in the mouse maximal electroshock seizure threshold model. Neurosci Res 2007;59:18-22.
22. Wie MB, Won MH, Lee KH, Shin JH, Lee JC, Suh HW, et al. Eugenol protects neuronal cells from excitotoxic and oxidative injury in primary cortical cultures. Neurosci Lett 1997;225:93-6.
23. Szabadics J, Erdelyi L. Pre-and postsynaptic effects of eugenol and related compounds on Helix pomatia L. neurons. Acta Biol Hung 2000;51:265-73.
24. Boissier JR, Simon P, Le Bourhis B. Experimental psychotropic action of cis-and trans-isomers of anethole. Therapie 1967;22:309-23.
25. Dallmeier K, Carlini EA. Anesthetic, hypothermic, myorelaxant and anticonvulsant effects of synthetic eugenol derivatives and natural analogues. Pharmacology 1981;22:113-27.